Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review

Sara Garfield, Sarah Clifford, Lina Eliasson, Nick Barber, Alan Willson, Sara Garfield, Sarah Clifford, Lina Eliasson, Nick Barber, Alan Willson

Abstract

Background: There is a recognised need to build primary care medication adherence services which are tailored to patients' needs. Continuous quality improvement of such services requires a regular working method of measuring adherence in order to monitor effectiveness. Self report has been considered the method of choice for clinical use; it is cheap, relatively unobtrusive and able to distinguish between intentional and unintentional non-adherence, which have different underlying causes and therefore require different interventions. A self report adherence measure used in routine clinical practice would ideally be brief, acceptable to patients, valid, reliable, have the ability to distinguish between different types of non-adherence and be able to be completed by or in conjunction with carers where necessary.

Methods: We systematically reviewed the literature in order to identify self report adherence measures currently available which are suitable for primary care and evaluate the extent to which they met the criteria described above. We searched the databases Medline, Embase, International Pharmaceutical Abstracts, Pharmline, CINAHL, PsycINFO and HaPI to identify studies reporting the development, validation or reliability of generic adherence measures. One reviewer screened all abstracts and assessed all relevant full text articles obtained and a second reviewer screened/assessed 10% to check reliability.

Results: Fifty eight measures were identified. While validation data were presented in support of the vast majority of self reported measures (54/58), data for a relatively small number of measures was presented for reliability (16/58) and time to complete (3/58). Few were designed to have the ability to be completed by or in conjunction with carers and few were able to distinguish between different types of non-adherence, which limited their ability be used effectively in the continuous improvement of targeted adherence enhancing interventions. The data available suggested that patients find it easier to estimate general adherence than to report a specific number of doses missed. Visual analogue scales can be easier for patients than other types of scale but are not suitable for telephone administration.

Conclusions: There is a need for a measure which can be used in the routine continual quality monitoring of adherence services.

Figures

Figure 1
Figure 1
Flow chart of papers identified, screened and evaluated.

References

    1. Department of Health. Pharmacy in England. Building on strengths-delivering the future. London: The Stationary Office; 2008.
    1. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. London: Cochrane Database of Systematic Reviews; 2008.
    1. Elliot R. Non-adherence to medicines - not solved but solvable. J Health Serv Res Policy. 2009;14:58–61. doi: 10.1258/jhsrp.2008.008088.
    1. Trueman P, Taylor DG, Lowson K, Blighe A, Meszaros A, Wright D, Glanville J, Newbould J, Bury M, Barber N, Jani YH. Evaluation of the Scale, Causes and Costs of Waste Medicines. York: University of York; 2010.
    1. Garfield S, Barber N, Walley P, Wilson A, Eliasson L. Quality of medicine use in primary care. Mapping the problem working to a solution. BMC Meds; 2009. p. 50.
    1. Horne R, Weinman J. Concordance, adherence and compliance in medicine taking. London: NCCSDO; 2006.
    1. National Collaborating Centre for Primary Care. Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. London: NICE; 2009.
    1. Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health and Quality of Life Outcomes. 2010;8:99. doi: 10.1186/1477-7525-8-99.
    1. Shi L, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices. Pharmacoeconomics. 2010;28:1097–1107. doi: 10.2165/11537400-000000000-00000.
    1. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The Concordance of Self-Report with Other Measures of Medication Adherence: A Summary of the Literature. Medical Care. 2004;42:649–652. doi: 10.1097/01.mlr.0000129496.05898.02.
    1. Francis SA, Smith FJ, Gray N, Denham M. Partnerships between older people and their carers in the management of medication. Journal of Older People Nursing. 2006;1:201–207. doi: 10.1111/j.1748-3743.2006.00032.x.
    1. Barber N, Safdar A, Franklin BD. Can human error theory explain? Pharmacy World Science. 2005;27:300–304. doi: 10.1007/s11096-005-0355-7.
    1. Bosworth HB, Voils CI. In: Patient treatment adherence: concept, interventions and measurement. Bosworth HB, Oddone EZ, Weinberger M, editor. Mahwah NJ: Lawrence Erlbaum Associates; 2006. Theoretical models to understand treatment adherence.
    1. Prochaska J, Diclemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. Journal of Consulting and Clinical Psychology. 1983;51:390–395.
    1. Ickovics J, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA. Consequences and determinents of adherence to antiretroviral medication: Results from adult AIDs clinical trials group protocol 370. Antiviral Therapy. 2002;7:185–193.
    1. Levine AJ, Hinkin CH, Marion S, Keuning A, Castellon SA, Lam MN, Robinet M, Longshore D, Newton T, Myers H, Durvasula Ramani S. Adherence to antiretroviral medications in HIV: Differences in data collected via self report and electronic monitoring. Health Psychology. 2006;25:329–335.
    1. Fletcher CV, Testa MA, Bundage RC, Chesney MA, Haubrich R, Acosta EP, Martinez A, Jiang H, Gulick R. Four measures of antiretroviral medication adherence and virologic response. Journal of Acquired Immune Deficiency Syndromes. 2005;40:301–306. doi: 10.1097/01.qai.0000180078.53321.6a.
    1. Llabre MM, Weaver KE, Duran RE, Antoni MH, Pherson-Baker S, Schneiderman N. A Measurement model of medication adherence to highly active Antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care and STDs. 2006;20:701–711. doi: 10.1089/apc.2006.20.701.
    1. Giordano TP, Guzman D, Clark R, Charlebois ED. Measuring adherence to antiretroviral therapy in a diverse population using a visual anologue scale. HIV Clinical Trials. 2004;5:74–79. doi: 10.1310/JFXH-G3X2-EYM6-D6UG.
    1. Mannheimer SB, Mukherjee R, Hirschhorn LR, Dougherty J, Celano SA, Ciccarone D, Graham KK, Mantell JE, Mundy LM, Eldred L, Botsko M, Finkelstein R. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy. AIDS Care. 2006;18:853–861. doi: 10.1080/09540120500465160.
    1. Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes. 2004;36:1100–1102. doi: 10.1097/00126334-200408150-00014.
    1. Murphy DA, Greenwell L, Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women and Health, 36, 97-111. Women and Health. 2002;36:97–111. doi: 10.1300/J013v36n01_07.
    1. Mugavero M, Ostermann J, Whetten K, Lsserman J, Swartz M, Stangdl D, Thielman N. Barriers to antiretroviral adherence: the importance of depression, abuse and other traumatic events. AIDS Patient Care & STDs. 2006;20:418–428. doi: 10.1089/apc.2006.20.418.
    1. Murphy DA, Sarr M, Durako SJ, Moscicki A, Wilson CM, Muenz LR. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Archives of Pediatrics and Adolescent Medicine. 2003;157:249–255.
    1. Zeller A, Ramseier E, Teagtmeyer A, Battegay E. Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertension Research - Clinical & Experimental. 2008;31:2037–43. doi: 10.1291/hypres.31.2037.
    1. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Adherence to antihypertensive medication assessed by self report was associated with electronic monitoring compliance. Journal of Clinical Epidemiology. 2006;59:650–651. doi: 10.1016/j.jclinepi.2005.10.013.
    1. Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. Journal of Clinical Epidemiology. 2008;61:282–8. doi: 10.1016/j.jclinepi.2007.04.007.
    1. Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value in Health. 2009;12:118–123. doi: 10.1111/j.1524-4733.2008.00400.x.
    1. Matza LS, Park J, Coyne KS, Skinner EP, Wolever RQ. Derivation and Validation of the ASK-12 Adherence Barrier Survey. Annals of Pharmacotherapy. 2009;43:1621–1630. doi: 10.1345/aph.1M174.
    1. Barroso PF, Schechter M, Gupta P, Bressan C, Bonfim H, Harrison LH. Adherence to antiretroviral therapy and persistence of HIV RNA in semen. Journal of Acquired Immune Deficiency Syndromes. 2003;1:435–440.
    1. Bell DJ, Kapitao Y, Sikwese R, van Oosterhout JJ, Lalloo DG. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. Journal of Acquired Immune Deficiency Syndromes. 2007;45:560–563. doi: 10.1097/QAI.0b013e3180decadb.
    1. Brooks CM, Richards JM, Kohler CL, Soong SJ. Assessing adherence to asthma medication and inhaler regimens: A psychometric analysis of adult self-report scales. Medical Care. 1994;32:298–307. doi: 10.1097/00005650-199403000-00008.
    1. Choo PW, Rand CS, Inui TS, Lee M. Validation of patient reports, automated pharmacy records and pill counts with electronic monitoring of adherence to antihypertensive therapy. Medical Care. 1999;37:846–857. doi: 10.1097/00005650-199909000-00002.
    1. Orensky IA, Holdford DA. Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic. Pharmacotherapy. 2005;25:1801–1808. doi: 10.1592/phco.2005.25.12.1801.
    1. Cohn SE, Kamman E, Wiliams P, Currier JS, Chesney MA. Association of adherence to mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in acquired immunodeficiency syndrome. Clinical infectious diseases. 2002;34:1129–1136. doi: 10.1086/339542.
    1. Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L. Assessing medication adherence among older persons in community settings. Canadian Journal of Clinical Pharmacology. 2005;12:152–164.
    1. Mannheimer S, Thackeray L, Huppler Hullsiek K, Chesney M, Gardner EM, Wu AW. A randomised comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care. 2008;20:161–169. doi: 10.1080/09540120701534699.
    1. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretoviral therapy predicts biological outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical infectious diseases. 2002;40:1115–1121.
    1. Erickson SR, Coombes JH, Kirking DM, Azimi AR. Compliance from self reported versus pharmacy claim data with metered dose inhalers. Annals of Pharmacotherapy. 2001;35:997–1003.
    1. Fodor G, Kotrec M, Bacskai K, Dorner T, Lietava J, Sonkodi S, Rieder A, Turton P. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central European study. Journal of Hypertension. 2005;23:1261–1266. doi: 10.1097/.
    1. Gehi AK, Ali S, Na B, Whooey MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease. Archives of Internal Medicine. 2007;167:1798–1803. doi: 10.1001/archinte.167.16.1798.
    1. Grymonpre RE, Didur CDMPR, Sitar DS. Pill count, self report and pharmacy claims data to measure medication adherence in the elderly. Annals of Pharmacotherapy. 1998;32:749–754. doi: 10.1345/aph.17423.
    1. Hill-Briggs F, Gary TL, Bone LR, Hill MN, Levine DM, Brancati FL. Medication adherence and diabetes control in urban African Americans with type 2 diabetes. Health Psychology. 2005;24:349–357.
    1. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development of the immunosupressant therapy adherence instrument. Patient Education & Counseling. 2004;59:13–20.
    1. Wilks SE, Spivey CA, Chisholm-Burns MA. Psychometric re-evaluation of the immunosuppressant therapy adherence scale among solid-organ transplant recipients. Journal of Evaluation in Clinical Practice. 2010;16:64–68. doi: 10.1111/j.1365-2753.2008.01115.x.
    1. Inui TS, Carter WB, Pecorara RE. Screening for non-compliance among patients with hypertension: is self report the best available measure? Medical Care. 1981;19:1061–1064. doi: 10.1097/00005650-198110000-00008.
    1. Kerr T, Hogg RS, Yip B, Tyndall MW, Montaner J, Wood E. Validity of self-reported adherence among injection drug users. Journal of the International Association of Physicians in AIDS Care. 2008;7:157–9. doi: 10.1177/1545109708320686.
    1. Leopold NA, Polansky M, Hurka MR. Drug adherence in Parkinson's disease. Movement Disorders. 2004;19:513–517. doi: 10.1002/mds.20041.
    1. Liu H, Miller LG, Hays RD, Wagner G, Golin CE, Hu W, Kahn K, Haubrich R, Kaplan AH, Wenger NS. A practical method to calibrate self-reported adherence to antiretroviral therapy.[Erratum appears in J Acquir Immune Defic Syndr. 2007 May 1;45(1):129] Journal of Acquired Immune Deficiency Syndromes. 2006;43:S104–1245. doi: 10.1097/01.qai.0000245888.97003.a3.
    1. Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, Wilson IB. Optimal recall period and response task for self-reported HIV medication adherence. AIDS & Behaviour. 2008;12:86–94.
    1. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. Journal of Acquired Immune Deficiency Syndromes. 2001;26:82–92.
    1. Butler JA, Peveler RC, Roderick P, Horne R, Mason JC. Measuring compliance with drug regimens after renal transplantation: Comparison of self-report and clinician rating with electronic monitoring. Transplantation. 2004;77:786–789. doi: 10.1097/01.TP.0000110412.20050.36.
    1. Jonsdottir H, Opjordsmoen S, Birkenaes AB, Engh JA, Ringen PA, Vaskinn A, Aamo TO, Andreassen OA. Medication adherence in outpatients with severe mental disorders: Relation between self-reports and serum level. Psychopharmacology. 2010;30:169–175. doi: 10.1097/JCP.0b013e3181d2191e.
    1. Lapshin O. Assessing medication adherence in clinical practice. Bridging Eastern and Western Psychiatry. 2006;4:42–45.
    1. Koneru S, Shishov M, Ware A, Farhey Y, Brunner HI. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis & Rheumatism. 2007;57:1000–1006. doi: 10.1002/art.22898.
    1. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16:269–277. doi: 10.1097/00002030-200201250-00017.
    1. Cook CL, Wade WE, Martin BC, Perri M III. Concordance among three self-reported measures of medication adherence and pharmacy refill records. Journal of the American Pharmacists Association. 2005;45:151–9. doi: 10.1331/1544345053623573.
    1. Melbourne K, Geletko SM, Brown SL, Willney-Lessene C, Chase S, Fisher A. Medication adherence in patients with HIV infection: a comparison of 2 measurement methods. The AIDS reader. 1999;10:177–185.
    1. Mooney M, Sayre S, Green C, Rhoadas H, Scmitz J. Comparing measures of medication taking in a pharmacotherapy trial for cocaine dependence. Addictive Disorders and Their Treatment. 2004;3:165–173. doi: 10.1097/.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986;24:67–74. doi: 10.1097/00005650-198601000-00007.
    1. Pratt RJ, Robinson N, Loveday HP, Pellowe CM, Franks PJ, Hankins M, Loveday C. Adherence to antiretroviral therapy: Appropriate use of self-reporting in clinical practice. HIV Clinical Trials. 2001;2:146–159. doi: 10.1310/89E2-XNJL-W107-R2GL.
    1. Holzemer W, Corless I, Nokes K, Turner J, Brown MA, Powell-Cope GM, Inouye J, Henry SB, Nicholas PK, Portillo CJ. Predictors of self reported adherence in persons living with HIV disease. AIDS Patient Care & STDs. 1999;13:185–197. doi: 10.1089/apc.1999.13.185.
    1. Sewitch MJ, Leffondre K, Dobkin PL. Clustering patients according to health perceptions. Relationships to health psychosocial characteristics and medication non-adherence. Journal of Psychosomatic Research. 2004;56:323–332. doi: 10.1016/S0022-3999(03)00508-7.
    1. Elixhauser A, Eisen SA, Romeis JC, Homan SM. The effects of monitoring and feedback on compliance? Medical Care. 1990;28:882–893. doi: 10.1097/00005650-199010000-00003.
    1. Shalansky SJ, Levy AR. Self-reported Morisky score for identifying nonadhrence with cardiovascular medications. Annals of Pharmacotherapy. 2004;38:1363–1368. doi: 10.1345/aph.1E071.
    1. George CF, Peveler RC, Helinger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. British Journal of Clinical Pharmacology. 2000;50:166–171. doi: 10.1046/j.1365-2125.2000.00244.x.
    1. Prado J, Kupek E, Mion J. Validity of four indirect methods to measure adherence in primary care hypertensives. Journal of Human Hypertension. 2007;21:579–584.
    1. Ruslami R, van CR, van de BE, Alisjahbana B, Aarnoutse RE. A step-wise approach to find a valid and feasible method to detect non-adherence to tuberculosis drugs. Southeast Asian Journal of Tropical Medicine & Public Health. 2008;39:1083–7.
    1. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension. 2008;10:348. doi: 10.1111/j.1751-7176.2008.07572.x.
    1. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. American Journal of Managed Care. 2009;15:59–66.
    1. Murphy DA, Wilson CM, Dukaro SJ, Muenz LR, Belzer M. Antiretroviral medication adherence among the Reach HIV infected adolescent cohort in the USA. AIDS Care. 2001;13:27–40. doi: 10.1080/09540120020018161.
    1. Murphy DA, Greenwell L, Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women and Health. 2002;36:97–111. doi: 10.1300/J013v36n01_07.
    1. Pratt SI, Mueser KT, Driscoll M, Wolfe R, Bartels SJ. Medication nonadherence in older people with serious mental illness: Prevalence and correlates. Psychiatric Rehabilitation Journal. 2006;29:299–310. doi: 10.2975/29.2006.299.310.
    1. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health. 1999;14:1–24.
    1. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Education and Counseling. 1999;37:113–124. doi: 10.1016/S0738-3991(98)00107-4.
    1. Remington G, Kwon G, Collins A, Laporte D, Mann S, Chrintenson B. The use of electronic monitoring (mems) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophrenia Research. 2007;90:229–237. doi: 10.1016/j.schres.2006.11.015.
    1. Schneider J, Kaplan S, Greenfield S, Wenjun L, Wilson I. Better physician-patient relationships are associated with higher reported adherence to antintiretroviral therapy in patients with HIV infection. Journal of General Internal Medicine. 2004;19:1096–1103. doi: 10.1111/j.1525-1497.2004.30418.x.
    1. Schuman P, Ohmit E, Cohen M, Sacks H, Richardson J, Young M, Schoenbaum E, Rompalo A, Gardner L. Prescription of and adherence to antiretroviral therapy among women with aids. AIDS & Behavior. 2001;5:371–378. doi: 10.1023/A:1013143024686.
    1. Munoz-Moreno JA, Fumaz CR, Ferrer MJ, Tuldra A, Rovira T, Viladrich C, Bayés R, Burger DM, Negredo E, Clotet B. SERAD Validation Team. Assessing self-reported adherence to HIV therapy by questionnaire: The SERAD (Self-Reported Adherence) study. AIDS Research and Human Retroviruses. 2007;23:1166–1175. doi: 10.1089/aid.2006.0120.
    1. Knobel H, Alonso J, Casado JL, Collazos J, Gonzalez J, Ruiz I, Kindelan JMG, Carmona A, Juega J, Ocampo A. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA study. AIDS. 2002;16:605–613. doi: 10.1097/00002030-200203080-00012.
    1. Knobel H, Vallecillo G, Guelar A, Pedrol E, Soler A, Carmona A. Simplified therapy with zidovudine, lamivudine and abacavir for very non adherent treatment failing patients. HIV Clinical Trials. 2004;5:65–73. doi: 10.1310/CW63-E5E4-M51K-91DR.
    1. Kalichman SC, Amaral CM, Swetzes C, Jones M, Macy R, Kalichman MO, Chauncey C. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. Journal of the International Association of Physicians in AIDS Care. 2009;8:367–374. doi: 10.1177/1545109709352884.
    1. Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, Melbourne K, Mitty J, Caro JJ. Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure. Clinical Therapeutics. 2000;22:858–871. doi: 10.1016/S0149-2918(00)80058-2.
    1. Rathbun RC, Farmer KC, Lockhart SM, Stephens JR. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection. Annals of Pharmacotherapy. 2007;41:208–215. doi: 10.1345/aph.1H383.
    1. Stewart M. The validity of an interview to assess a patient's drug taking. American Journal of Preventive Medicine. 1987;3:95–100.
    1. George J, Mackinnon A, Kong DCM, Stewart K. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ) Patient Education & Counseling. 2006;64:50–60. doi: 10.1016/j.pec.2005.11.010.
    1. Greaves CJ, Hyland ME, Halpin DMG, Blake S, Seamark D. Patterns of corticosteroid medication use: Non-adherence can be effective in milder asthma. Primary Care Respiratory Journal. 2005;14:99–105. doi: 10.1016/j.pcrj.2004.09.005.
    1. Walsh JC, Horne R, Dalton M, Burgess A, Gazzard BG. Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes. AIDS Care. 2001;13:709–720. doi: 10.1080/09540120120076878.
    1. Nau DP, Steinke DT, Williams LK, Austin R, Pladevall M. Adherence analysis using visual analog scale versus claims-based estimation. Annals of Pharmacotherapy. 2007;41:1792–1797. doi: 10.1345/aph.1K264.
    1. Muller AD, Bode S, Myer L, Roux P, Von SN. Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa. Pediatric Infectious Disease Journal. 2008;27:257–262. doi: 10.1097/INF.0b013e31815b1ad4.
    1. Holzemer WL, Bakken S, Portillo CJ, Grimes R, Welch J, Wantland D, Mullan JT. Testing a nurse tailored HIV medication adherence intervention. Nursing Research. 2006;55:189–197. doi: 10.1097/00006199-200605000-00005.
    1. Chesney MA. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care. 2000;12:255–266. doi: 10.1080/09540120050042891.
    1. Wagner G, Miller LG. Is the influence of social desirability on patients' self reported adherence overrated? Journal of Acquired Immune Deficiency Syndromes. 2004;35:203–204. doi: 10.1097/00126334-200402010-00016.
    1. Paterson D, Swindells S, Mohr J. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Archives of Internal Medicine. 2000;133:21–30.
    1. Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, Apperley JF, Szydlo R. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. Journal of Clinical Oncology. 2010;28:2381–2388. doi: 10.1200/JCO.2009.26.3087.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj